Lite Strategy, Inc.

2.0800+0.15 (+7.77%)

Oct 29, 4:00:01 PM EDT · NasdaqCM · LITS · USD

Upcoming Earnings

Report date

≈ Nov 11, 2025 (in 12 days)

Key Stats

Market Cap

74.16M

P/E (TTM)

Basic EPS (TTM)

-2.39

Dividend Yield

Recent Filings

10-K

9/26/25Sep 26, 2025

8-K

9/15/25Sep 15, 2025

8-K

9/10/25Sep 10, 2025

8-K

9/4/25Sep 4, 2025

8-K

8/6/25Aug 6, 2025

About

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

CEO

Mr. Justin J. File CPA

IPO

12/18/2003

Website

https://www.litestrategy.com

Employees

Sector

Healthcare

Industry

Biotechnology